Afuco™ Anti-MUC5AC ADCC Therapeutic Antibody (Ensituximab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to 5AC. Ensituximab is a chimeric monoclonal antibody used in the treatment of cancers.
Supplier Creative Biolabs
Product # AFC-TAB-200
Pricing Inquiry
Host Chimeric
Target MUC5AC
Species Reactivity Human
Type ADCC enhanced antibody
Applications IP, IF, FuncS, FC, Neut, ELISA
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback